SELLAS Life Sciences (SLS) Gross Profit (2020 - 2022)
Historic Gross Profit for SELLAS Life Sciences (SLS) over the last 3 years, with Q1 2022 value amounting to $900000.0.
- SELLAS Life Sciences' Gross Profit fell 8392.86% to $900000.0 in Q1 2022 from the same period last year, while for Dec 2022 it was $900000.0, marking a year-over-year decrease of 8783.78%. This contributed to the annual value of $900000.0 for FY2022, which is 8783.78% down from last year.
- Per SELLAS Life Sciences' latest filing, its Gross Profit stood at $900000.0 for Q1 2022, which was down 8392.86% from $1.8 million recorded in Q2 2021.
- In the past 5 years, SELLAS Life Sciences' Gross Profit ranged from a high of $5.6 million in Q1 2021 and a low of $900000.0 during Q1 2022
- For the 3-year period, SELLAS Life Sciences' Gross Profit averaged around $2.6 million, with its median value being $1.8 million (2020).
- Examining YoY changes over the last 5 years, SELLAS Life Sciences' Gross Profit showed a top increase of 8392.86% in 2022 and a maximum decrease of 8392.86% in 2022.
- SELLAS Life Sciences' Gross Profit (Quarter) stood at $1.9 million in 2020, then dropped by 5.26% to $1.8 million in 2021, then tumbled by 50.0% to $900000.0 in 2022.
- Its last three reported values are $900000.0 in Q1 2022, $1.8 million for Q2 2021, and $5.6 million during Q1 2021.